OWC Pharmaceutical Research Corp (OWCP)

[skitahoe]

Moxa,

Let me preface this with the fact that I want OWCP to remain an independently trading stock, but that doesn't mean we couldn't effectively be controlled by another. A company that has say 25% or more stock in another company effectively can run it, because in a shareholders vote, it's practically impossible to defeat something they are supporting.

That said, what if a big Pharma did like the intellectual property represented by OWCP, including all they might develop in the future, and they made an offer to take say a 30% position in the company. What sort of price do you believe such an offer might bring?

I will agree with you that growing essentially on it's own a billion dollar market cap would be a major achievement for the end of the year, possible but I don't think anyone would be unhappy with half of that. On the other hand, I believe if a big Pharma wanted a 30% interest in the company, I believe they'd need to offer billions, I don't know how many, but more than one.

I'm not saying this will happen, or that during the year we'll get any huge partnership, it's more likely we'll get one or more smaller one, but "What If" questions are always interesting, and this is one that could take the market cap to billions essentially instantaneously.

I do believe the possibility exists here, and as a shareholder I'd certainly be thrilled with it, however long term I'm not certain we'd not do better if we remained totally independent. If independent, I suspect that a decade from now our share price could be in triple digits, I'm not certain that would happen with a big Pharma in control, and I don't know that we wouldn't be rolled into the big Pharma in that time. I'm reminded of what Roche did with Genentech, initially purchasing it, then spinning it off partially, and ultimately repurchasing it completely. Don't get me wrong, the shareholders were well rewarded, but I'm uncertain they wouldn't have been even further ahead with an independent Genentech.

Happy New Year's,

Gary